Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram

Table of Contents

August 24, 2020; Volume 192,Issue 34
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Abu-Raya, Bahaa

    1. You have access
      Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic
      Bahaa Abu-Raya, Soren Gantt and Manish Sadarangani
      CMAJ August 24, 2020 192 (34) E982-E985; DOI: https://doi.org/10.1503/cmaj.201237

B

  1. Bailey, Dana

    1. You have access
      SARS-CoV-2 (COVID-19) serology: implications for clinical practice, laboratory medicine and public health
      Paul Van Caeseele, for the Canadian Public Health Laboratory Network, Dana Bailey, for the Canadian Society of Clinical Chemists, Sarah E. Forgie, for the Association of Medical Microbiology and Infectious Disease Canada, Tanis C. Dingle, for the Canadian Association for Clinical Microbiology and Infectious Diseases, Mel Krajden and for the COVID-19 Immunity Task Force
      CMAJ August 24, 2020 192 (34) E973-E979; DOI: https://doi.org/10.1503/cmaj.201588
  2. Banning, Jolene

    1. You have access
      Why are Indigenous communities seeing so few cases of COVID-19?
      Jolene Banning
      CMAJ August 24, 2020 192 (34) E993-E994; DOI: https://doi.org/10.1503/cmaj.1095891
  3. Bloomfield, Valerie

    1. You have access
      Five things to know about …: Placenta accreta spectrum
      Valerie Bloomfield, Stacey Rogers and Nicholas Leyland
      CMAJ August 24, 2020 192 (34) E980; DOI: https://doi.org/10.1503/cmaj.200304

C

  1. Chong, Mei

    1. You have access
      Vulnerable Populations: Toxicology and prescribed medication histories among people experiencing fatal illicit drug overdose in British Columbia, Canada
      Alexis Crabtree, Emily Lostchuck, Mei Chong, Aaron Shapiro and Amanda Slaunwhite
      CMAJ August 24, 2020 192 (34) E967-E972; DOI: https://doi.org/10.1503/cmaj.200191
  2. Crabtree, Alexis

    1. You have access
      Vulnerable Populations: Toxicology and prescribed medication histories among people experiencing fatal illicit drug overdose in British Columbia, Canada
      Alexis Crabtree, Emily Lostchuck, Mei Chong, Aaron Shapiro and Amanda Slaunwhite
      CMAJ August 24, 2020 192 (34) E967-E972; DOI: https://doi.org/10.1503/cmaj.200191

D

  1. Dingle, Tanis C.

    1. You have access
      SARS-CoV-2 (COVID-19) serology: implications for clinical practice, laboratory medicine and public health
      Paul Van Caeseele, for the Canadian Public Health Laboratory Network, Dana Bailey, for the Canadian Society of Clinical Chemists, Sarah E. Forgie, for the Association of Medical Microbiology and Infectious Disease Canada, Tanis C. Dingle, for the Canadian Association for Clinical Microbiology and Infectious Diseases, Mel Krajden and for the COVID-19 Immunity Task Force
      CMAJ August 24, 2020 192 (34) E973-E979; DOI: https://doi.org/10.1503/cmaj.201588

E

  1. Embil, John M.

    1. You have access
      Clinical Images: Minocycline-induced cutaneous hyperpigmentation
      Lauren Shute, Andrew Walkty and John M. Embil
      CMAJ August 24, 2020 192 (34) E981; DOI: https://doi.org/10.1503/cmaj.200012

F

  1. Fantus, Daniel

    1. You have access
      Safely restarting renal transplant programs should be a priority
      Daniel Fantus and Michel R. Pâquet
      CMAJ August 24, 2020 192 (34) E988; DOI: https://doi.org/10.1503/cmaj.76277
  2. Forgie, Sarah E.

    1. You have access
      SARS-CoV-2 (COVID-19) serology: implications for clinical practice, laboratory medicine and public health
      Paul Van Caeseele, for the Canadian Public Health Laboratory Network, Dana Bailey, for the Canadian Society of Clinical Chemists, Sarah E. Forgie, for the Association of Medical Microbiology and Infectious Disease Canada, Tanis C. Dingle, for the Canadian Association for Clinical Microbiology and Infectious Diseases, Mel Krajden and for the COVID-19 Immunity Task Force
      CMAJ August 24, 2020 192 (34) E973-E979; DOI: https://doi.org/10.1503/cmaj.201588

G

  1. Gantt, Soren

    1. You have access
      Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic
      Bahaa Abu-Raya, Soren Gantt and Manish Sadarangani
      CMAJ August 24, 2020 192 (34) E982-E985; DOI: https://doi.org/10.1503/cmaj.201237

K

  1. Kmet, Alexander

    1. You have access
      Encounters: The gift of peace
      Alexander Kmet
      CMAJ August 24, 2020 192 (34) E989-E990; DOI: https://doi.org/10.1503/cmaj.200360
  2. Krajden, Mel

    1. You have access
      SARS-CoV-2 (COVID-19) serology: implications for clinical practice, laboratory medicine and public health
      Paul Van Caeseele, for the Canadian Public Health Laboratory Network, Dana Bailey, for the Canadian Society of Clinical Chemists, Sarah E. Forgie, for the Association of Medical Microbiology and Infectious Disease Canada, Tanis C. Dingle, for the Canadian Association for Clinical Microbiology and Infectious Diseases, Mel Krajden and for the COVID-19 Immunity Task Force
      CMAJ August 24, 2020 192 (34) E973-E979; DOI: https://doi.org/10.1503/cmaj.201588

L

  1. Leyland, Nicholas

    1. You have access
      Five things to know about …: Placenta accreta spectrum
      Valerie Bloomfield, Stacey Rogers and Nicholas Leyland
      CMAJ August 24, 2020 192 (34) E980; DOI: https://doi.org/10.1503/cmaj.200304
  2. Lostchuck, Emily

    1. You have access
      Vulnerable Populations: Toxicology and prescribed medication histories among people experiencing fatal illicit drug overdose in British Columbia, Canada
      Alexis Crabtree, Emily Lostchuck, Mei Chong, Aaron Shapiro and Amanda Slaunwhite
      CMAJ August 24, 2020 192 (34) E967-E972; DOI: https://doi.org/10.1503/cmaj.200191

M

  1. Murray, Terry

    1. You have access
      This is way more complicated than anyone expected …
      Terry Murray
      CMAJ August 24, 2020 192 (34) E991-E992; DOI: https://doi.org/10.1503/cmaj.1095890

P

  1. Pâquet, Michel R.

    1. You have access
      Safely restarting renal transplant programs should be a priority
      Daniel Fantus and Michel R. Pâquet
      CMAJ August 24, 2020 192 (34) E988; DOI: https://doi.org/10.1503/cmaj.76277

R

  1. Rogers, Stacey

    1. You have access
      Five things to know about …: Placenta accreta spectrum
      Valerie Bloomfield, Stacey Rogers and Nicholas Leyland
      CMAJ August 24, 2020 192 (34) E980; DOI: https://doi.org/10.1503/cmaj.200304

S

  1. Sadarangani, Manish

    1. You have access
      Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic
      Bahaa Abu-Raya, Soren Gantt and Manish Sadarangani
      CMAJ August 24, 2020 192 (34) E982-E985; DOI: https://doi.org/10.1503/cmaj.201237
  2. Shapiro, Aaron

    1. You have access
      Vulnerable Populations: Toxicology and prescribed medication histories among people experiencing fatal illicit drug overdose in British Columbia, Canada
      Alexis Crabtree, Emily Lostchuck, Mei Chong, Aaron Shapiro and Amanda Slaunwhite
      CMAJ August 24, 2020 192 (34) E967-E972; DOI: https://doi.org/10.1503/cmaj.200191
  3. Shute, Lauren

    1. You have access
      Clinical Images: Minocycline-induced cutaneous hyperpigmentation
      Lauren Shute, Andrew Walkty and John M. Embil
      CMAJ August 24, 2020 192 (34) E981; DOI: https://doi.org/10.1503/cmaj.200012
  4. Slaunwhite, Amanda

    1. You have access
      Vulnerable Populations: Toxicology and prescribed medication histories among people experiencing fatal illicit drug overdose in British Columbia, Canada
      Alexis Crabtree, Emily Lostchuck, Mei Chong, Aaron Shapiro and Amanda Slaunwhite
      CMAJ August 24, 2020 192 (34) E967-E972; DOI: https://doi.org/10.1503/cmaj.200191

T

  1. Tyndall, Mark

    1. You have access
      Vulnerable Populations: A safer drug supply: a pragmatic and ethical response to the overdose crisis
      Mark Tyndall
      CMAJ August 24, 2020 192 (34) E986-E987; DOI: https://doi.org/10.1503/cmaj.201618

V

  1. Van Caeseele, Paul

    1. You have access
      SARS-CoV-2 (COVID-19) serology: implications for clinical practice, laboratory medicine and public health
      Paul Van Caeseele, for the Canadian Public Health Laboratory Network, Dana Bailey, for the Canadian Society of Clinical Chemists, Sarah E. Forgie, for the Association of Medical Microbiology and Infectious Disease Canada, Tanis C. Dingle, for the Canadian Association for Clinical Microbiology and Infectious Diseases, Mel Krajden and for the COVID-19 Immunity Task Force
      CMAJ August 24, 2020 192 (34) E973-E979; DOI: https://doi.org/10.1503/cmaj.201588

W

  1. Walkty, Andrew

    1. You have access
      Clinical Images: Minocycline-induced cutaneous hyperpigmentation
      Lauren Shute, Andrew Walkty and John M. Embil
      CMAJ August 24, 2020 192 (34) E981; DOI: https://doi.org/10.1503/cmaj.200012
Back to top
PreviousNext

In this issue

Canadian Medical Association Journal: 192 (34)
CMAJ
Vol. 192, Issue 34
24 Aug 2020
  • Table of Contents
  • Index by author

Issue highlights

  • Toxicology and prescribed medication histories among people experiencing fatal illicit drug overdose in British Columbia, Canada
  • A safer drug supply: a pragmatic and ethical response to the overdose crisis
  • SARS-CoV-2 (COVID-19) serology: implications for clinical practice, laboratory medicine and public health
  • Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic
Sign up for alerts
  • Most Read
  • Most Cited
  • Responses
Loading
  • Canada’s response to the initial 2 years of the COVID-19 pandemic: a comparison with peer countries
  • Patient–physician language concordance and quality and safety outcomes among frail home care recipients admitted to hospital in Ontario, Canada
  • Antiviral drug treatment for nonsevere COVID-19: a systematic review and network meta-analysis
  • The war in Ukraine and refugee health care: considerations for health care providers in Canada
  • Stomach bug or COVID?
More...

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2022, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire